| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 466,307 | 297,644 | 213,787 | 400,967 | | Cost of Revenue | 377,023 | 239,181 | 166,039 | 289,257 | | | Gross Profit | 89,284 | 58,463 | 47,748 | 111,710 | | | Operating Expenses | | Research Development | 8,250 | 6,853 | 7,964 | 5,970 | | Selling General and Administrative | 46,473 | 41,755 | 42,283 | 50,599 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 34,561 | 9,855 | (2,499) | 55,141 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 585 | 24,765 | (5,973) | (20,069) | | Earnings Before Interest And Taxes | 35,146 | 34,620 | (8,472) | 35,072 | | Interest Expense | 9,854 | 9,528 | 6,121 | 101 | | Income Before Tax | 25,292 | 25,092 | (14,593) | 34,971 | | Income Tax Expense | 15,088 | 4,054 | (8,562) | 19,499 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,831 | 24,171 | (4,786) | 29,549 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,831 | 24,171 | (4,786) | 29,549 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,831 | $24,171 | ($4,786) | $29,549 |
|
0.51% Nasdaq 
Income Statement
